Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Concentra Group Holdings Inc. (CON:NYSE), powered by AI.
Concentra Group Holdings Inc. is currently trading at $28.13. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Concentra Group Holdings Inc. on Alpha Lenz.
View Concentra Group Holdings Inc.'s valuation metrics on Alpha Lenz.
“Concentra Group Holdings Inc.'s ROE is 49.8%. Explore profitability and growth together.”
Ask for details →Concentra Group Holdings Inc. is a prominent player in the healthcare and occupational health services industry. As a subsidiary of Select Medical Holdings Corporation, Concentra provides a comprehensive range of medical services, primarily focusing on occupational medicine, urgent care, and physical therapy. It serves a diverse array of clients, including employees of large corporations, small businesses, and government entities. The company’s primary aim is to ensure workforce health and productivity by offering preventive care, injury treatment, and wellness programs. Through its extensive network of medical centers and on-site clinics, Concentra plays a crucial role in reducing workplace injuries and managing employee health, directly impacting industries that rely heavily on workforce efficiency such as manufacturing, transportation, and construction. Moreover, by delivering critical health services, the company contributes significantly to the broader healthcare ecosystem. Founded with a mission to provide convenient and effective healthcare solutions, Concentra Group Holdings Inc. continues to adapt to evolving healthcare demands, reinforcing its position as a key participant in the occupational health market.
“Concentra Group Holdings Inc.'s ROE is 49.8%. Explore profitability and growth together.”
Ask for details →Concentra Group Holdings Inc. (ticker: CON) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 8,758 employees.
The current price is $28.13 with a P/E ratio of -x and P/B of -x.
ROE is 49.75% and operating margin is 15.44%. Annual revenue is $2.2B.